|
|
|
|
Novartis Pharma AG Satellite Symposium
Thursday November 13, 2008
11.00 – 13.00
Programme
Optimising the treatments of today,
understanding the treatments of tomorrow
Chair: G. Comi |
|
|
|
| 11.00 |
Introduction |
G. Comi |
| |
|
|
| 11.10 |
Current perspectives on optimising interferon treatment |
M. Comabella |
| |
|
|
| 11.45 |
Oral fingolimod: the Phase II evidence
Oral fingolimod: the Phase III promise |
G. Comi |
| |
|
|
| 12.15 |
Sphingosine1-phosphate (S1-P) receptor modulation:
effects on the immune and central nervous system |
V. Brinkmann
|
| |
|
|
| 12.50 |
Questions and summary |
G. Comi |
| |
|
|
| 13.00 |
Closure |
|
Print this page Tell-a-friend
|
